Skip to main content
. 2004 Oct;186(19):6443–6456. doi: 10.1128/JB.186.19.6443-6456.2004

TABLE 1.

Oligonucleotides used in this study

Oligonucleotide Sequence (5′ to 3′)a Purpose
BB0647FWD ATGAACGACAACATAATAGACG PCR primer
BB0647REV TAAAGTGATTTCCTTGTTCTCATC PCR primer
FLAF GGTATAATCATATGAACGACAACATAATAGAC PCR primer
FRR ATGACTCGAGTTATATTCATAAAGTGAT PCR primer
U-19 mer GTTTTCCCAGTCACGACGT PCR primerb
T7 promoter TAATACGACTCACTATAGGG PCR primer
GBBEG25F CAAACTTGGAGAAAACTGG PCR primer
GBBEG25R CGAACATAAAGTGATTTCCTTG PCR primer
GBBDA28F TATGAAAATAAATAAATAATAAGTAG PCR primer
GBBDA28R CGAACATATGATTATACCTTTTTTG PCR primer
GBBBM12F TTATGCATTGTACTTAAATTGC PCR primer
GBBBM12R CGAACATAACTATCTCCTTTA PCR primer
FurF GGGGATAATGATAATCATTATCGGG Fur box sequencec
FurR CCCGATAATGATTATCATTATCCCC Fur box sequence
PerRF2 GGGCTAAATTATAATTATTATAATTTAGGGG Per box sequence
PerRR2 CCCCTAAATTATAATAATTATAATTTAGCCC Per box sequence
LMFv2 GTATGCGTTGGTACCGCTGCTGGGGGC Control sequence
LMRv2 GCCCCCAGCAGCGGTACCAACGCATAC Control sequence
a

Restriction sites for subsequent cloning of the PCR products are underlined.

b

The U-19 mer and T7 promoter primers were from Novagen.

c

The oligonucleotides used for the Fur box sequence were from Gonzalez de Peredo et al. (25).